Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for C1C7Q3

Entry ID Method Resolution Chain Position Source
AF-C1C7Q3-F1 Predicted AlphaFoldDB

No variants for C1C7Q3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for C1C7Q3

No associated diseases with C1C7Q3

3 regional properties for C1C7Q3

Type Name Position InterPro Accession
domain DnaJ domain 4 - 80 IPR001623
domain Chaperone DnaJ, C-terminal 120 - 276 IPR002939
conserved_site DnaJ domain, conserved site 46 - 65 IPR018253

Functions

Description
EC Number 6.3.4.16 Other carbon--nitrogen ligases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

3 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity Catalysis of the reaction: 2 ATP + L-glutamine + CO2 + H2O = 2 ADP + phosphate + glutamate + carbamoyl phosphate.
metal ion binding Binding to a metal ion.

2 GO annotations of biological process

Name Definition
'de novo' UMP biosynthetic process The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen.
arginine biosynthetic process The chemical reactions and pathways resulting in the formation of arginine, 2-amino-5-(carbamimidamido)pentanoic acid.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MPKRTDIQKI MVIGSGPIII GQAAEFDYAG TQACLSLKEE GYEVVLVNSN PATIMTDKEI
70 80 90 100 110 120
ADKVYIEPIT LEFVTRILRK EGPDALLPTL GGQTGLNMAM ELSKNGILDE LGVELLGTKL
130 140 150 160 170 180
SAIDQAEDRD LFKQLMEELE QPIPESEIVN TVEEAVAFAA TIGYPVIVRP AFTLGGTGGG
190 200 210 220 230 240
MCANEKELRE ITENGLKLSP VTQCLIERSI AGFKEIEYEV MRDSADNALV VCNMENFDPV
250 260 270 280 290 300
GIHTGDSIVF APAQTMSDYE NQMLRDASLS IIRALKIEGG CNVQLALDPN SFKYYVIEVN
310 320 330 340 350 360
PRVSRSSALA SKATGYPIAK LAAKIAVGLT LDEVINPVTG STYAMFEPAL DYVVAKIPRF
370 380 390 400 410 420
PFDKFEKGER RLGTQMKATG EVMAIGRNIE ESLLKACRSL EIGVHHNEIP ELAAVSDDAL
430 440 450 460 470 480
IEKVVKAQDD RLFYVSEAIR RGYTPEEIAE LTKIDIFYLD KLLHIFEIEQ ELGAHPQDLE
490 500 510 520 530 540
VLKTAKLNGF SDRKIAELWG TTDDQVRQLR LENKIVPVYK MVDTCAAEFD SETPYFYSTY
550 560 570 580 590 600
GWENESIRSD KESVLVLGSG PIRIGQGVEF DYATVHSVKA IQAAGYEAII MNSNPETVST
610 620 630 640 650 660
DFSVSDKLYF EPLTFEDVMN VIDLEQPKGV IVQFGGQTAI NLAEPLAKAG VTILGTQVAD
670 680 690 700 710 720
LDRAEDRDLF EQALKELDIP QPPGQTATNE EEAALAARKI GFPVLVRPSY VLGGRAMEIV
730 740 750 760 770 780
ENEEDLRSYM RTAVKASPDH PVLVDSYIVG QECEVDAISD GKDVLIPGIM EHIERAGVHS
790 800 810 820 830 840
GDSMAVYPPQ TLSQKVQETI ADYTKRLAIG LHCLGMMNIQ FVIKDEKVYV IEVNPRASRT
850 860 870 880 890 900
VPFLSKVTNI PMAQVATKLI LGQSLSELGY QNGLYPESTR VHIKAPVFSF TKLAKVDSLL
910 920 930 940 950 960
GPEMKSTGEV MGSDATLEKA LYKAFEASYL HLPTFGNVVF TIADDAKEEA LNLARRFQNI
970 980 990 1000 1010 1020
GYGILATEGT AAFFASHGLQ AQPVGKIGDD DKDIPSFVRK GRIQAIINTV GTKRTADEDG
1030 1040 1050
EQIRRSAIEH GVPLFTALDT ANAMLKVLES RSFVTEAI